Effect of long-term triphasic oral contraceptive use on glucose tolerance and insulin secretion

Obstetrics and Gynecology

Volumn 78, Issue 1, 1991, Pages 108-114

  Gillespy, Marjorie ^a,b   Notelovitz, Morris ^a,b   Ellingson, Anne B ^a,b   Khan, Farouk Y ^a,b  

^a Climacteric Clink Inc Women’s Medical and Diagnostic Center ^*  (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORETHISTERONE; INSULIN; LEVONORGESTREL; NORETHISTERONE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; COMPARATIVE STUDY; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, SYNTHETIC; ETHINYL ESTRADIOL; ETHINYL ESTRADIOL-NORGESTREL COMBINATION; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN; MESTRANOL; NORETHINDRONE; NORGESTREL; PROSPECTIVE STUDIES; RANDOM ALLOCATION; STATISTICS; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0025905134     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Stout RW. Insulin and atheroma—an update. Lancet 1987;i:1077–9.
2. LaRosa JC. Atherosclerotic risk factors in cardiovascular disease. J Reprod Med 1986;31(suppl):906–11.
3. Zavaroni I, Bonora E, Pagliara M, et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 1989;320:702–6.
4. Russell-Briefel R, Ezzati TM, Perlman JA, Murphy RS. Impaired glucose tolerance in women using oral contraceptives: United States, 1976–1980. J Chronic Dis 1987;40:3–11.
5. Rabe T, Runnebaum B. Progestins and carbohydrate metabolism. Int J Fertil 1986;31(suppl):31–45.
6. Spellacy WN. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives. Am J Obstet Gynecol 1987;142:732–4.
7. Crook D, Godsland IF, Wynn V. Oral contraceptives and coronary heart disease: Modulation of glucose tolerance and plasma lipid risk factors by progestins. Am J Obstet Gynecol 1988;158:1612–20.
8. van der Vange N, Kloosterboer HJ, Haspels AA. Effect of seven low-dose oral contraceptive preparations on carbohydrate metabolism. Am J Obstet Gynecol 1987;156:918–22.
9. Gaspard UJ. Metabolic effects of oral contraceptives. Am J Obstet Gynecol 1987;157:1029–41.
10. Perlman JA, Russell-Briefel R, Ezzati T, Lieberknecht B. Oral glucose tolerance and the potency of contraceptive progestins. J Chronic Dis 1985;38:857–64.
11. Gosland IF, Crook D, Simpson R, et al. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med 1990;323:1375–81.
12. Vexiau P, Gautray JP, Lelorier G, Thibult N, Cathelineau G. Amelioration paradoxale de l’intolerance au glucose chez 8 femmes sous contraception oestroprogestative contenant du norgestrel et do l’ethinyl-estradiol. Diabete Metab 1985;11:359–63.
13. Kalkhoff RK. Effects of oral contraceptive agents on carbohydrate metabolism. J Steroid Biochem 1975;6:949–56.
14. Kung AW, Ma JT, Wong VC, et al. Glucose and lipid metabolism with triphasic oral contraceptives in women with history of gestational diabetes. Contraception 1987;35:257–69.
15. Wingrave SJ, Kay CR, Vessey MP. Oral contraceptives and diabetes mellitus. Br Med J 1979;1:23.
16. Rabe T, Runnebaum B, Kohlmeyer M, Weicker H. Lipid, carbohydrate, and androgen metabolism in women using a triphasic oral contraceptive containing norethindrone for one year. Int J Fertil 1986;31(suppl):46–52.
17. Spellacy WN, Ellingson AB, Kotlik A, Tsibris JCM. Prospective study of carbohydrate metabolism in women using a triphasic oral contraceptive containing norethindrone and ethinyl estradiol for 3 months. Am J Obstet Gynecol 1988;159:877–9.
18. Spellacy WN, Ellingson AB, Kotlik A, Tsibris JCM. Plasma glucose and insulin levels in women using a levonorgestrel-containing triphasic oral contraceptive for three months. Contraception 1988;38:27–35.
19. Spellacy WN, Ellingson AB, Tsibris JCM. Glucose and insulin levels after six months of treatment with a triphasic oral contraceptive containing ethinyl estradiol and norethindrone. J Reprod Med 1989;34:540–2.
20. Spellacy WN, Ellingson AB, Tsibris JCM. The effects of two triphasic oral contraceptives on carbohydrate metabolism in women during 1 year of use. Fertil Steril 1989;51:71–4.
21. Rubeck-Petersen K, Skouby SO, Dreisler A, Kuhl C, Svenstrup B. Comparative trial of the effects on glucose tolerance and lipoprotein metabolism of two new oral contraceptives containing gestodene and desogestrel. Acta Obstet Gynecol Scand 1988;67:37–41.
22. Wynn V, Godsland I. Effects of oral contraceptives on carbohydrate metabolism. J Reprod Med 1986;31:892–7.
23. Stampfer MJ, Willett WC, Colditz GA, Speizer FE, Hennedens CH. A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases. N Engl J Med 1988;319:1313–7.